ChromaDex (CDXC)
(Delayed Data from NSDQ)
$3.63 USD
-0.07 (-1.89%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.62 -0.01 (-0.28%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum B VGM
ChromaDex (CDXC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.23 | $6.70 | $6.00 | 68.38% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for ChromaDex comes to $6.23. The forecasts range from a low of $6.00 to a high of $6.70. The average price target represents an increase of 68.38% from the last closing price of $3.70.
Analyst Price Targets (3 )
Broker Rating
ChromaDex currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | Roth Capital Partners | Sean P Mcgowan | Strong Buy | Strong Buy |
7/15/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $6.23 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 253 |
Current Quarter EPS Est: | 0.01 |
CDXC FAQs
ChromaDex Corporation (CDXC) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for ChromaDex Corporation (CDXC) is $6.23. The current on short-term price targets is based on 3 reports.
The forecasts for ChromaDex Corporation (CDXC) range from a low of $6 to a high of $6.7. The average price target represents a increase of $68.38 from the last closing price of $3.70.
The current UPSIDE for ChromaDex Corporation (CDXC) is 68.38%
Based on short-term price targets offered by three analysts, the average price target for ChromaDex comes to $6.23. The forecasts range from a low of $6.00 to a high of $6.70. The average price target represents an increase of 68.38% from the last closing price of $3.70.